Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Infective Endocarditis
2005 Standout
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens
2001 Standout
Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)
1996
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
2002 Standout
MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison
2006
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Site‐directed mutagenesis of β‐lactamase TEM‐1
1993
Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients
1998
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases
1994
Antibacterial Dosing in Intensive Care
2006
Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 β-lactamase of Pseudomonas aeruginosa
1991
The epidemiology of human listeriosis
2007 Standout
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Decreased transmission of Enterobacteriaceae with extended-spectrum β-lactamases in an intensive care unit by nursing reorganization
1995
Streptococcus pneumoniaeBacteremia: Duration of Previous Antibiotic Use and Association with Penicillin Resistance
2003
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
2004 Standout
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Epidemiological typing of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital
1997
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
2001
Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins
1990
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
1997
A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey
1999
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
1990
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
2009 StandoutNobel
Methicillin-Resistant Staphylococcus aureus
1989 Standout
The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospital
1998
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
2006
Comparison of screening methods for detection of extended‐spectrum β‐lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong
2000
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
2012 Standout
Skin Hygiene and Infection Prevention: More of the Same or Different Approaches?
1999 Standout
High‐Level Penicillin‐NonsusceptibleStreptococcus pneumoniaeBacteremia: Identification of a Low‐Risk Subgroup
2004
Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae
1999
Principles of antibacterial dosing in continuous renal replacement therapy
2009
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Comparison of susceptibility to extended-spectrum β-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units
1995
Sexually transmitted diseases treatment guidelines
2003 Standout
Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula
1997
Novel carbenicillin-hydrolyzing β-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus
1989
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media
1998
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains
2000
Cefepime Versus Cefpirome: The Importance of Creatinine Clearance
2003
Staphylococcus aureusInfections
1998 Standout
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data
2003
Treatment of Gonococcal Conjunctivitis With Single-Dose Intramuscular Ceftriaxone
1989
beta-Lactamases in laboratory and clinical resistance
1995
The population dynamics of antimicrobial chemotherapy
1997
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases
1994
Extended-spectrum beta-lactamases
1989 Standout
Updated Functional Classification of β-Lactamases
2009 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Detection et distribution des beta-lactamases a spectre elargi chez les enterobacteries
1988
Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1
1986
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Effect of Amoxicillin Use on Oral Microbiota in Young Children
2004
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis
1988
Enterobacter spp.: pathogens poised to flourish at the turn of the century
1997
Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB)
1991
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
Ability of Laboratories To Detect Emerging Antimicrobial Resistance: Proficiency Testing and Quality Control Results from the World Health Organization's External Quality Assurance System for Antimicrobial Susceptibility Testing
2001
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Inhibitor-Based Methods for Detection of Plasmid-Mediated AmpC β-Lactamases in Klebsiella spp., Escherichia coli , and Proteus mirabilis
2005
[Surveillance of multiresistant bacteria: justification, role of the laboratory, indicators, and recent French data].
1998
More extended-spectrum beta-lactamases
1991
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
1996 Standout
TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli
1989
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Antimicrobial resistance of Staphylococcus aureus: genetic basis
1987
Acinetobacter calcoaceticus variete Anitratus ou Acinetobacter baumannii Etude de la sensibilité aux antibiotiques de 65 souches hospitalières
1988
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Nucleotide Sequence of the bla RTG-2 (CARB-5) Gene and Phylogeny of a New Group of Carbenicillinases
2000
Transformation of Arthrobacter and studies on the transcription of the Arthrobacter ermA gene in Streptomyces lividans and Escherichia coli
1987 StandoutNobel
Detection of plasmid-mediated beta-lactamases with DNA probes
1988
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Étude phare. Étude comparative de l'association céfépime-amikacine versus ceftazidime en association avec l'amikacine dans le traitement des pneumonies nosocomiales chez les patients ventilés
1999
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Genetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type ß-Lactamase, RTG-4, from Acinetobacter baumannii
2009
The Crisis in Antibiotic Resistance
1992 StandoutScience
Ciprofloxacin–Photoswitch Conjugates: A Facile Strategy for Photopharmacology
2015 StandoutNobel
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis
1997
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium
1997
A functional classification scheme for beta-lactamases and its correlation with molecular structure
1995 Standout
Oligonucleotide probes (TEM-1, OXA-1) versus isoelectric focusing in beta-lactamase characterization of 114 resistant strains
1988
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro
1985
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli
1986
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator
1986
Works of A Thabaut being referenced
In-vitro development of resistance to β-lactam antibiotics in Streptococcus pneumoniae
1995
Definition of the Clinical Antibacterial Spectrum of Activity
1996
In-vitro antibacterial activity of cefepime: a multicentre study
1993
In Vitro Development of Resistance of Streptococcus pneumoniae to β-Lactam Antibiotics
1995
Possible prevention of in vitro selection of resistantStreptococcus pneumoniae by beta-lactamase inhibitors
1994
A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France
1992
Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa
1994
Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83)
1985
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
1989
Comparative in vitro Activity of 8 Cephalosporins on 109 Strains of <i>Neisseria gonorrhoeae</i> and 60 Strains of <i>Neisseria meningitidi</i><i>s</i>
1981
[Frequency and distribution of beta-lactamases in 1792 strains of Klebsiella pneumoniae in France between 1985 and 1988].
1990
Incidence et distribution des beta-lactamases constitutives de Pseudomonas aeruginosa (1981–1986). consequences sur la sensibilite aux beta-lactamines
1989
Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa
1986
[Sensitivity of Pseudomonas aeruginosa and Klebsiella spp. to ceftazidime. Current status in France].
1988
[Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
1985
Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de 1989 à 1993
1995
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
1982
[In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase].
1991
Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis.
1994
beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.
1985
[Distribution of constituent beta-lactamases in Pseudomonas aeruginosa].
1984